182 related articles for article (PubMed ID: 11522101)
1. Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy.
Nishimura M; Sasaki T; Ohishi A; Oishi M; Kono S; Totani Y; Kato Y; Noto Y; Misaki S; Higashi K; Shimada F; Wakasugi H; Inoue K; Hoshiyama Y; Yamada K
Clin Nephrol; 2001 Aug; 56(2):96-103. PubMed ID: 11522101
[TBL] [Abstract][Full Text] [Related]
2. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Jin SM; Han KA; Yu JM; Sohn TS; Choi SH; Chung CH; Park IeB; Rhee EJ; Baik SH; Park TS; Lee IK; Ko SH; Hwang YC; Cha BS; Lee HW; Nam MS; Lee MK
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2108-14. PubMed ID: 27493100
[TBL] [Abstract][Full Text] [Related]
3. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy.
Sato A; Tabata M; Hayashi K; Saruta T
Clin Exp Nephrol; 2003 Sep; 7(3):215-20. PubMed ID: 14586718
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective effect of the addition of losartan to ongoing treatment with an angiotensin converting enzyme inhibitor in type-2 diabetic patients with nephropathy.
Abe H; Minatoguchi S; Ohashi H; Murata I; Minagawa T; Okuma T; Yokoyama H; Takatsu H; Takaya T; Nagano T; Osumi Y; Kakami M; Tsukamoto T; Tanaka T; Hiei K; Fujiwara H
Hypertens Res; 2007 Oct; 30(10):929-35. PubMed ID: 18049024
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
Shigihara T; Sato A; Hayashi K; Saruta T
Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
Banu N; Hara H; Okamura M; Egusa G; Yamakido M
Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
[TBL] [Abstract][Full Text] [Related]
7. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
8. Urinary type IV collagen levels in diabetes mellitus.
Sthaneshwar P; Chan SP
Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
[TBL] [Abstract][Full Text] [Related]
9. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.
Gambaro G; Kinalska I; Oksa A; Pont'uch P; Hertlová M; Olsovsky J; Manitius J; Fedele D; Czekalski S; Perusicová J; Skrha J; Taton J; Grzeszczak W; Crepaldi G
J Am Soc Nephrol; 2002 Jun; 13(6):1615-25. PubMed ID: 12039991
[TBL] [Abstract][Full Text] [Related]
10. Probucol suppresses initiation of chronic hemodialysis therapy and renal dysfunction-related death in diabetic nephropathy patients: Sakura study.
Endo K; Saiki A; Yamaguchi T; Sakuma K; Sasaki H; Ban N; Kawana H; Nagayama D; Nagumo A; Ohira M; Oyama T; Murano T; Miyashita Y; Yamamura S; Suzuki Y; Shirai K; Tatsuno I
J Atheroscler Thromb; 2013; 20(5):494-502. PubMed ID: 23363981
[TBL] [Abstract][Full Text] [Related]
11. Probucol delays progression of diabetic nephropathy.
Endo K; Miyashita Y; Sasaki H; Ohira M; Saiki A; Koide N; Otsuka M; Oyama T; Takeyoshi M; Ito Y; Shirai K
Diabetes Res Clin Pract; 2006 Feb; 71(2):156-63. PubMed ID: 16009446
[TBL] [Abstract][Full Text] [Related]
12. Urinary type IV collagen excretion predicts subsequent declining renal function in type 2 diabetic patients with proteinuria.
Katavetin P; Katavetin P; Susantitaphong P; Townamchai N; Tiranathanagul K; Tungsanga K; Eiam-Ong S
Diabetes Res Clin Pract; 2010 Aug; 89(2):e33-5. PubMed ID: 20542586
[TBL] [Abstract][Full Text] [Related]
13. Effect of tranilast in early-stage diabetic nephropathy.
Soma J; Sato K; Saito H; Tsuchiya Y
Nephrol Dial Transplant; 2006 Oct; 21(10):2795-9. PubMed ID: 16820373
[TBL] [Abstract][Full Text] [Related]
14. The role of determining the levels of serum collagen type IV in diagnosing early diabetic nephropathy.
Xu X; Wu Z; Zhou Q; Zhang Y; Wu D
Ren Fail; 2002 Nov; 24(6):747-53. PubMed ID: 12472197
[TBL] [Abstract][Full Text] [Related]
15. Effects of losartan on urinary secretion of extracellular matrix and their modulators in type 2 diabetes mellitus patients with microalbuminuria.
Woo V; Ni LS; Hak D; Berard L; Zhu F; Khan S; Ma GM; Penner B; Shen GX
Clin Invest Med; 2006 Dec; 29(6):365-72. PubMed ID: 17330452
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of alacepril, a new angiotensin-converting enzyme inhibitor on albuminuria and glycemic state: an open multicenter trial. Alacepril Study Group.
Utsunomiya K; Ikeda Y
J Diabet Complications; 1991; 5(2-3):165-6. PubMed ID: 1770032
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
18. Influence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitus.
Wainai H; Katsukawa F; Takei I; Maruyama H; Kataoka K; Saruta T
J Diabet Complications; 1991; 5(2-3):160-1. PubMed ID: 1722805
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.
Chuahirun T; Simoni J; Hudson C; Seipel T; Khanna A; Harrist RB; Wesson DE
Am J Med Sci; 2004 Feb; 327(2):57-67. PubMed ID: 14770020
[TBL] [Abstract][Full Text] [Related]
20. Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.
Vilarrasa N; Soler J; Montanya E
Acta Diabetol; 2005 Jun; 42(2):87-94. PubMed ID: 15944842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
